Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

Ovarian Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Amir Jazaeri, MD) · aajazaeri@mdanderson.org · +1 (713) 745-1613
Contact: Principal Investigator (Amir Jazaeri)

Study leads

Clinical Trials
Study Director
Theolytics Ltd

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Colitis · Diarrhea · Malignant Genitourinary System Neoplasm

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Using Aspirin to Improve Immunological Features of Ovarian Tumors

Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Tampa, United States · Portland, United States

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Renal Cell Carcinoma (RCC) · Lung Cancer · Anaplastic Thyroid Carcinomas

Abroad (travel likely)RecruitingPHASE1

Hefei, China

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Pancreatic Cancer · Renal Cell Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States